Previous close | 5.43 |
Open | 5.43 |
Bid | 5.78 x 440000 |
Ask | 5.83 x 420000 |
Day's range | 5.43 - 5.99 |
52-week range | 1.97 - 13.70 |
Volume | |
Avg. volume | 307 |
Market cap | 424.846M |
Beta (5Y monthly) | 0.10 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | 20 Jan 2017 |
1y target est | N/A |
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
Altimmune ( NASDAQ:ALT ) First Quarter 2024 Results Key Financial Results Net loss: US$24.4m (loss widened by 22% from...